Newbridge Financial Services Group, Inc. Ampio Pharmaceuticals, Inc. Transaction History

Newbridge Financial Services Group, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	BUY	$0.56 - $1.71 $1,960 - $5,985	3,500 Added 53.85%	10,000 $6,000
Q2 2021 Sep 07, 2021	BUY	$1.56 - $1.98 $2,340 - $2,970	1,500 Added 30.0%	6,500 $11,000
Q1 2021 Sep 07, 2021	BUY	$1.36 - $2.49 $4,080 - $7,470	3,000 Added 150.0%	5,000 $8,000
Q4 2020 Sep 07, 2021	BUY	$0.75 - $2.76 $1,500 - $5,520	2,000 New	2,000 $3,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.